Showing results (421-430 of 449) with videos related to
Sort By:
Pageof 45
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.Nature Communications|November 17, 2020
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastomaKonstantin Helmsauer, Maria E Valieva, Salaheddine Ali, et al.Haematologica|February 16, 2023
Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantationAmadeus T Heinz, Friso G J Calkoen, Alexander Derbich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.International Journal of Cancer|October 29, 2014
MiR-34a deficiency accelerates medulloblastoma formation in vivoTheresa Thor, Annette Künkele, Kristian W Pajtler, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 10, 2026
European expert recommendations for comprehensive pre-treatment, treatment-phase and post-treatment care of patients with metachromatic leukodystrophy treated with autologous haematopoietic stem and progenitor cell gene therapyLucia Laugwitz, Francesca Fumagalli, Katharina Wehner, et al.Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.Nature Genetics|October 9, 2012
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppressionJan J Molenaar, Raquel Domingo-Fernández, Marli E Ebus, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.Cancer Discovery|January 10, 2024
Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in CancerYi Bei, Luca Bramé, Marieluise Kirchner, et al.Pageof 45